Document Detail


Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
MedLine Citation:
PMID:  18349296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is one of the most abundant carcinogens in smokeless tobacco products. NNK uptake by measurement of the urinary metabolites 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (total NNAL) has been reported in many studies, but there are no data in the literature on the percentage of the NNK dose that is converted to NNAL in smokeless tobacco users. In this study, 15 male subjects abstained from tobacco use for 3 weeks before placing 2 g smokeless tobacco between their cheeks and gums for 30 min. They then continued abstinence and collected three consecutive 24-h urine samples. The amount of NNK in the tobacco before and after use was determined along with the amount in expectorated saliva. The NNK dose thus calculated was compared with the amount of total NNAL excreted in the next 72 h. These data, taken together with previous pharmacokinetic data, show that the percent conversion of NNK to total NNAL in smokeless tobacco users is approximately 14% to 17%. This figure can be used to calculate daily exposure to NNK in smokeless tobacco users ( approximately 6 microg). The results of this study also indicate that metabolic activation of NNK to intermediates that can react with DNA is its major pathway of metabolism in smokeless tobacco users.
Authors:
Stephen S Hecht; Steven G Carmella; Irina Stepanov; Joni Jensen; Amanda Anderson; Dorothy K Hatsukami
Related Documents :
1581396 - Effects of inhaled nicotine on instrumental learning of blood pressure responses.
7317896 - Treatment of angina pectoris with propranolol: the harmful effects of cigarette smoking.
8058616 - The use of fourier transform infrared (ft-ir) spectroscopy to determine the diffusion c...
7590426 - Effect of drink temperature on antropyloroduodenal motility and gastric electrical acti...
15105226 - Changes in splanchnic circulation during an alveolar recruitment maneuver in healthy po...
16277726 - Recruitment maneuvers and positive end-expiratory pressure/tidal ventilation titration ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  17     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-03-19     Completed Date:  2008-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  732-5     Citation Subset:  IM    
Affiliation:
The Cancer Center and Transdisciplinary Tobacco Use Research Center, University of Minnesota Cancer Center, Minneapolis, MN 55455, USA. hecht002@umn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Glucuronates / urine*
Humans
Male
Nitrosamines / urine*
Tobacco, Smokeless*
Grant Support
ID/Acronym/Agency:
CA-81301/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid; 0/Glucuronates; 0/Nitrosamines; 64091-91-4/4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagit...
Next Document:  No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's...